Nanjing Hicin Pharmaceutical Co Ltd (300584) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.007x

Based on the latest financial reports, Nanjing Hicin Pharmaceutical Co Ltd (300584) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-7.15 Million ≈ $-1.05 Million USD) by net assets (CN¥1.07 Billion ≈ $157.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Nanjing Hicin Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Nanjing Hicin Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Nanjing Hicin Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.

Nanjing Hicin Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanjing Hicin Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Beijing Science Sun Pharmaceutical Co Ltd SHE:300485	0.008x
Shandong Realcan Pharmaceutical Co Ltd SHE:002589	-0.003x
GCM Grosvenor Inc NASDAQ:GCMG	0.423x
Zhejiang Orient Gene Biotech Co Ltd SHG:688298	-0.005x
Sinovac Biotech Ltd NASDAQ:SVA	0.013x
New York Mortgage Trust Inc NASDAQ:NYMT	0.028x
PIMCO Access Income Fund NYSE:PAXS	N/A
Shenzhen Xfh Technology Co Ltd SHE:300890	-0.022x

Annual Cash Flow Conversion Efficiency for Nanjing Hicin Pharmaceutical Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Nanjing Hicin Pharmaceutical Co Ltd (300584) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.10 Billion ≈ $160.94 Million	CN¥78.09 Million ≈ $11.43 Million	0.071x	+22.93%
2024-12-31	CN¥1.04 Billion ≈ $151.92 Million	CN¥59.96 Million ≈ $8.77 Million	0.058x	+138.31%
2023-12-31	CN¥987.50 Million ≈ $144.50 Million	CN¥23.93 Million ≈ $3.50 Million	0.024x	+495.88%
2022-12-31	CN¥950.57 Million ≈ $139.10 Million	CN¥-5.82 Million ≈ $-851.55K	-0.006x	-109.69%
2021-12-31	CN¥948.48 Million ≈ $138.79 Million	CN¥59.94 Million ≈ $8.77 Million	0.063x	-41.53%
2020-12-31	CN¥678.97 Million ≈ $99.35 Million	CN¥73.39 Million ≈ $10.74 Million	0.108x	-27.33%
2019-12-31	CN¥653.98 Million ≈ $95.70 Million	CN¥97.28 Million ≈ $14.23 Million	0.149x	+11.91%
2018-12-31	CN¥580.93 Million ≈ $85.01 Million	CN¥77.21 Million ≈ $11.30 Million	0.133x	+47.79%
2017-12-31	CN¥517.68 Million ≈ $75.75 Million	CN¥46.56 Million ≈ $6.81 Million	0.090x	-34.20%
2016-12-31	CN¥276.11 Million ≈ $40.40 Million	CN¥37.74 Million ≈ $5.52 Million	0.137x	-40.39%
2015-12-31	CN¥235.08 Million ≈ $34.40 Million	CN¥53.90 Million ≈ $7.89 Million	0.229x	+88.91%
2014-12-31	CN¥200.15 Million ≈ $29.29 Million	CN¥24.29 Million ≈ $3.55 Million	0.121x	-55.41%
2013-12-31	CN¥165.93 Million ≈ $24.28 Million	CN¥45.16 Million ≈ $6.61 Million	0.272x	-6.87%
2012-12-31	CN¥132.65 Million ≈ $19.41 Million	CN¥38.77 Million ≈ $5.67 Million	0.292x	--

About Nanjing Hicin Pharmaceutical Co Ltd

SHE:300584 China Drug Manufacturers - Specialty & Generic

Market Cap

$642.69 Million

CN¥4.39 Billion CNY

Market Cap Rank

#11302 Global

#3330 in China

Share Price

CN¥36.60

Change (1 day)

-3.84%

52-Week Range

CN¥27.90 - CN¥77.88

All Time High

CN¥83.16